Literature DB >> 23477745

Does the Framingham cardiovascular disease risk score also have predictive utility for dementia death? An individual participant meta-analysis of 11,887 men and women.

Tom C Russ1, Mark Hamer, Emmanuel Stamatakis, John M Starr, G David Batty, Mika Kivimäki.   

Abstract

OBJECTIVE: Individual cardiovascular disease (CVD) risk factors are associated with dementia. For the first time, we investigated whether the Framingham CVD risk score-which comprises these multiple risk factors-was also associated with future dementia risk.
METHODS: Individual participant meta-analysis of two large, general population cohort studies (N = 11,887). For the purposes of comparison of the dementia results, we also examined the association between the Framingham CVD risk score and CVD-related death.
RESULTS: Framingham CVD risk score was associated with dementia death (hazard ratio per 10% increased risk, 95% confidence interval: 4.00, 2.44-6.56). Adjusting for age eliminated this association (1.04, 0.53-2.01); similarly, age explained 88% of the ability of the Framingham CVD risk score to predict CVD death.
CONCLUSIONS: The Framingham CVD risk score was no more strongly associated with future dementia than age. It therefore offers no added value in predicting dementia.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23477745     DOI: 10.1016/j.atherosclerosis.2013.02.020

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  9 in total

1.  The Framingham risk score is associated with incident frailty, or is it?

Authors:  Hui Shi; Mei-Ling Ge; Birong Dong; Qian-Li Xue
Journal:  BMC Geriatr       Date:  2021-07-31       Impact factor: 3.921

2.  Height in relation to dementia death: individual participant meta-analysis of 18 UK prospective cohort studies.

Authors:  Tom C Russ; Mika Kivimäki; John M Starr; Emmanuel Stamatakis; G David Batty
Journal:  Br J Psychiatry       Date:  2014-11       Impact factor: 9.319

3.  Examining if being overweight really confers protection against dementia: Sixty-four year follow-up of participants in the Glasgow University alumni cohort study.

Authors:  G David Batty; Bruna Galobardes; John M Starr; Mona Jeffreys; George Davey Smith; Tom C Russ
Journal:  J Negat Results Biomed       Date:  2016-11-02

4.  Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients.

Authors:  Abdelkader Chalghoum; Yosri Noichri; Azza Dandana; Bruno Baudin; Abdelhédi Miled; Salima Ferchichi
Journal:  BMC Cardiovasc Disord       Date:  2016-11-29       Impact factor: 2.298

5.  Risk prediction models for dementia: role of age and cardiometabolic risk factors.

Authors:  Aurore Fayosse; Dinh-Phong Nguyen; Aline Dugravot; Julien Dumurgier; Adam G Tabak; Mika Kivimäki; Séverine Sabia; Archana Singh-Manoux
Journal:  BMC Med       Date:  2020-05-19       Impact factor: 8.775

6.  Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis.

Authors:  Ruth Peters; Andrew Booth; Kenneth Rockwood; Jean Peters; Catherine D'Este; Kaarin J Anstey
Journal:  BMJ Open       Date:  2019-01-25       Impact factor: 2.692

7.  Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis.

Authors:  G David Batty; Catharine R Gale; Mika Kivimäki; Ian J Deary; Steven Bell
Journal:  BMJ       Date:  2020-02-12

8.  Modifiable cardiovascular disease risk factors as predictors of dementia death: pooling of ten general population-based cohort studies.

Authors:  G David Batty; Tom C Russ; John M Starr; Emmanuel Stamatakis; Mika Kivimäki
Journal:  J Negat Results Biomed       Date:  2014-05-23

9.  Predicting dementia in primary care patients with a cardiovascular health metric: a prospective population-based study.

Authors:  Johannes Baltasar Hessler; Karl-Heinz Ander; Monika Brönner; Thorleif Etgen; Hans Förstl; Holger Poppert; Dirk Sander; Horst Bickel
Journal:  BMC Neurol       Date:  2016-07-26       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.